About Invitros
Invitros is a company based in Gangseo (South Korea) founded in 2023. It operates as a B2B. Invitros operates in a competitive market with competitors including OpGen, QuantuMDx, Avails Medical, Oxford Immunotec and NOWDiagnostics, among others.
- Headquarter Gangseo, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Invitros
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Invitros
Detailed funding history for Invitros
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invitros
Investment portfolio details for Invitros
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Invitros
Detailed financials for Invitros
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invitros Comparisons
Peer comparison for Invitros
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invitros
Invitros operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, QuantuMDx, Avails Medical, Oxford Immunotec and NOWDiagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| Locked | Locked | Locked |
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
|
|
| Locked | Locked | Locked |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays and automation platforms are developed.
|
Detailed competitors of Invitros
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invitros
Complete news archive for Invitros
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invitros
Invitros was founded in 2023.
Invitros is headquartered in Gangseo, South Korea.
Invitros, established in 2023, excels in providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and in-vitro solutions. Develops innovative in-vitro diagnostic technologies for allergies, tuberculosis, and respiratory diseases. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Invitros's top competitors include QuantuMDx, Avails Medical and OpGen.